Mupirocin for Skin Infection: Clinical Experience from China
Infection and Drug Resistance · 2024-09 · Volume 17 · 3955-3966
DOI: 10.2147/idr.s475611 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infection and Drug Resistance, 2024-09. Verfasst von Jing Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical & Scientific Affairs, Haleon (Formerly GSK Consumer Healthcare), Shanghai, People's Republic of China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical & Scientific Affairs, Haleon (Formerly GSK Consumer Healthcare), Shanghai, People's Republic of China.
- Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, National Center for Childre…
ORCID-Profile: Zigang Xu
Zitieren
APA
Sun, J., Lu, T., Dang, Y., Xu, Z., & Liu, Y. (2024). Mupirocin for Skin Infection: Clinical Experience from China. Infection and Drug Resistance, Volume 17, 3955-3966. https://doi.org/10.2147/idr.s475611
Vancouver
Sun J, Lu T, Dang Y, Xu Z, Liu Y. Mupirocin for Skin Infection: Clinical Experience from China. Infection and Drug Resistance. 2024;Volume 17:3955-3966. doi:10.2147/idr.s475611
BibTeX
@article{Sun2024,
author = {Sun, Jing and Lu, Tracy and Dang, Yan and Xu, Zigang and Liu, Ying},
title = {Mupirocin for Skin Infection: Clinical Experience from China},
journal = {Infection and Drug Resistance},
year = {2024},
volume = {Volume 17},
pages = {3955--3966},
doi = {10.2147/idr.s475611}
}
EUVIMED